Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06039319
Other study ID # 4967
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date November 1, 2022
Est. completion date June 30, 2024

Study information

Verified date September 2023
Source University of Tennessee Graduate School of Medicine
Contact Jill M Maples, PhD
Phone 8653059367
Email jmaples1@utmck.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Objectives / Specific Aims - The purpose of this study is to investigate the acute effects of a single bout of moderate intensity maternal exercise on fetal well-being in a pregnancy affected by fetal growth restriction. Fetal well-being will be measured by biophysical profile (BPP), non-stress test (NST) and umbilical artery dopplers. - The hypothesis is that a single bout of maternal exercise will not significantly alter fetal well-being or fetal status.


Description:

Background and Significance Regular exercise during pregnancy is beneficial in many ways, including decreased rates of diabetes or hypertensive disorders and decreased risks of preterm birth and cesarean deliveries. Many people use exercise to treat anxiety and depression as well as meet gestational weight gain recommendations. Regular exercise, defined as 150 minutes of moderate intensity exercise per week, is recommended in uncomplicated pregnancies. In some summary statements, fetal growth restriction (FGR) is noted as a relative or absolute contraindication to regular exercise. The American College of Obstetrics and Gynecology (ACOG), however, does not list FGR as a contraindication to maternal exercise. Currently, there are few high-quality studies about the effect of a recommended amount of maternal exercise on acute fetal status in pregnancies affected by FGR. The existing theories conflict. One theory is that maternal exercise will divert blood flow away from the uterus/fetus which could be deleterious in an already compromised pregnancy. The other theory is that exercise increases cardiac output and would therefore increase blood flow to the fetus. A previous study evaluated growth restricted fetuses after a single 5-minute bout of maternal exercise. This study population was heterogenous and used non-standardized measures of fetal assessment, making the results difficult to clinically interpret. In a previous study of healthy pregnancies, 30 minutes of moderate maternal exercise has been determined to have no effect on acute fetal status. The current study seeks to understand the acute fetal response to a single maternal exercise episode in pregnancies affected by FGR.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date June 30, 2024
Est. primary completion date June 30, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Inclusion Criteria - FGR population - Age 18-45 - Intrauterine pregnancy with diagnosis of fetal growth restriction (FGR) as defined by total estimated fetal weight <10%ile for EGA or abdominal circumference <10%ile for EGA - Diagnosis of FGR at any point in gestation (preference given for inclusion of those diagnosed with FGR after 32w0d) - Gestational age between 28w0d and 36w6d at time of intervention (based on sure last menstrual period (LMP) confirmed by first or second trimester ultrasound or unsure LMP with first trimester ultrasound) - Compliant with standard prenatal care Inclusion Criteria - Average for gestational age (AGA) population - Age 18-45 - Intrauterine pregnancy with normal estimated fetal growth (EFW >10%ile and <90%ile) - Gestational age between 28w0d and 36w6d at time of intervention with accurate dating (based on sure LMP confirmed by ultrasound prior to 22 weeks or unsure LMP with first trimester ultrasound) - Compliant with standard prenatal care Exclusion Criteria: - Exclusion Criteria - FGR population - Known contraindication to completion of 30 minutes of moderate intensity exercise - Fetal umbilical artery with elevated S/D ratio or absent or reversed diastolic flow - BMI >40 - Severe maternal anemia (Hb less than 8.0) - Placenta previa - 2nd or 3rd trimester vaginal bleeding - Preterm premature rupture of membranes - Cervical insufficiency - Multi-fetal gestation - Oligohydramnios - Hypertensive disorder requiring antihypertensive medication - Blood pressure >140/90 on the day of the study visit prior to exercise - Tobacco use - Opioid agonist therapy - Known fetal chromosomal anomaly, structural anomaly or infection - Inability or unwillingness of subject to give informed consent - Current psychiatric illness/social situation that would limit compliance with study requirements, as determined by the principle investigators Exclusion Criteria - AGA population - Known contraindication to completion of 30 minutes of moderate intensity exercise - BMI >40 - Severe maternal anemia (Hb less than 8.0) - Placenta previa - 2nd or 3rd trimester vaginal bleeding - Preterm premature rupture of membranes - Cervical insufficiency - Multi-fetal gestation - Oligohydramnios - Hypertensive disorder requiring antihypertensive medication - Blood pressure >140/90 on the day of the study visit prior to exercise - Tobacco use - Opioid agonist therapy - Known fetal chromosomal anomaly, structural anomaly or infection - Inability or unwillingness of subject to give informed consent - Current psychiatric illness/social situation that would limit compliance with study requirements, as determined by the principle investigators

Study Design


Intervention

Other:
Physical activity
30 minute bout of moderate intensity physical activity performed on a treadmill

Locations

Country Name City State
United States University of Tennessee Graduate School of Medicine Knoxville Tennessee

Sponsors (1)

Lead Sponsor Collaborator
University of Tennessee Graduate School of Medicine

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in umbilical artery dopplers systolic/diastolic ratio from pre to post exercise Change in physiological assessment of umbilical artery dopplers systolic/diastolic ratio measured using ultrasound Pre to immediately post acute exercise
Secondary Change in uterine artery dopplers from pre to post exercise Change in physiological assessment of uterine artery dopplers measured using ultrasound Pre to immediately post acute exercise
Secondary Change in fetal middle cerebral arterial (MCA) dopplers pulsatility index from pre to post exercise Change in physiological assessment of fetal middle cerebral arterial (MCA) dopplers pulsatility index measured using ultrasound Pre to immediately post acute exercise
Secondary Biophysical Profile (BPP) pre exercise Physiological assessment of Biophysical Profile (BPP) pre exercise using ultrasound, which assesses and scores fetal wellbeing in the following areas: body movement, muscle tone, breathing movements, and amniotic fluid volume. Each component of the biophysical profile receives a score of 0-2, with a total potential score ranging from 0-8. A score of 0 reflects fetal a fetal emergency and/or ominous fetal status and a score of 8 is regarded as "reassuring" which means normal. Pre exercise (within 1 hour of the start of acute exercise bout)
Secondary Time to complete Biophysical Profile (BPP) pre exercise Time to complete physiological assessment of Biophysical Profile (BPP) pre exercise. Pre exercise (within 1 hour of the start of acute exercise bout)
Secondary Biophysical Profile (BPP) post exercise Physiological assessment of Biophysical Profile (BPP) post exercise using ultrasound, which assesses and scores fetal wellbeing in the following areas: body movement, muscle tone, breathing movements, and amniotic fluid volume. Each component of the biophysical profile receives a score of 0-2, with a total potential score ranging from 0-8. A score of 0 reflects fetal a fetal emergency and/or ominous fetal status and a score of 8 is regarded as "reassuring" which means normal. Immediately post acute exercise
Secondary Time to complete Biophysical Profile (BPP) post exercise Time to complete physiological assessment of Biophysical Profile (BPP). Immediately post acute exercise
Secondary Change in blood glucose from pre to immediately post acute exercise Change in physiological assessment of capillary blood glucose measured using glucometer Pre (within 1 hour of the start of acute exercise bout) to immediately post acute exercise
Secondary Change in blood lactate from pre to immediately post acute exercise Change in physiological assessment of capillary blood lactate using lactate analyzer Pre (within 1 hour of the start of acute exercise bout) to immediately post acute exercise
Secondary Change in maternal mood Change in maternal mood using the Brunel Mood Scale Questionnaire. The Brunel Mood Scale is a 32-item questionnaire of current mood descriptors, assessed via 5-point Likert scale questions ("not at all" 0 to "extremely" 4). Mood descriptors are arranged into 8 different subscales (anger, confusion, depression, fatigue, tension, vigor, happiness, calmness), which have a scoring range from 0-16. Higher scores correspond to greater presence of the subscale. Pre (within 1 hour of the start of acute exercise bout) to 20 minutes post exercise
Secondary Change in maternal anxiety Change in maternal anxiety using the State Trait Anxiety Inventory (STAI) forms Y1 (20 items) and Y2 (20 items) which assess state and trait anxiety. Each STAI item is given a weighted score of 1 to 4. Scores for both the state anxiety and trait anxiety scales can vary from a minimum of 20 to a maximum of 80, where a higher score reflects higher anxiety. Pre (within 1 hour of the start of acute exercise bout) to 20 minutes post exercise
See also
  Status Clinical Trial Phase
Recruiting NCT05899101 - The Impact of Opioid and Cannabis Exposure on Fetal Growth
Completed NCT04502823 - Management of Fetal Growth Restriction at Term: Angiogenic Factors Versus Feto-placental Doppler N/A
Not yet recruiting NCT03625518 - Mode of Induction in Fetal Growth Restriction and Its Affects on Fetal and Maternal Outcomes Early Phase 1
Completed NCT05176041 - SLE Therapy Changes in Pregnancy and Relation to Pregnancy Outcome
Completed NCT02379728 - Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth N/A
Completed NCT01695070 - Melatonin to Prevent Brain Injury in Unborn Growth Restricted Babies Phase 4
Completed NCT01352234 - Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of Preeclampsia Phase 4
Not yet recruiting NCT05284474 - Management of Early-onset Fetal Growth Restriction: Angiogenic Factors Versus Feto-placental Doppler N/A
Completed NCT04289350 - Day to Day Variation in Fetal Heart Rate Variability
Recruiting NCT03662178 - Investigating the Structured Use of Ultrasound Scanning for Fetal Growth
Recruiting NCT05023161 - Non-invasive Placental Chromosome Exploration of Intrauterine Growth Restriction
Completed NCT02590536 - A Trial Evaluating the Role of Sildenafil in the Treatment of Fetal Growth Restriction Phase 3
Not yet recruiting NCT05029778 - Arginine + Citrulline as a Supplement for Weight Gain in Fetus With a Decrease in Their Growth Curve Phase 4
Recruiting NCT05576207 - BEP Supplementation Research in Bangladesh (JiVitA-BEP-IR) N/A
Active, not recruiting NCT05160649 - Effect of Covid 19 Infection on Fetomaternal Outcome
Completed NCT02280031 - Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial. Phase 2
Recruiting NCT04389099 - MRI Angiography of Physiological and Pathological Pregnancy Placentas Ex-vivo
Recruiting NCT05651347 - Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction Phase 3
Recruiting NCT02336243 - A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation Disorders Phase 3
Active, not recruiting NCT01594463 - Routine Ultrasound Screening in the Third Trimester N/A